{
    "doi": "https://doi.org/10.1182/blood.V130.Suppl_1.1606.1606",
    "article_title": "Second Generation Tyrosine Kinase Inhibitors (2G-TKI) in the Frontline Treatment of Elderly Patients with Chronic Myeloid Leukemia ",
    "article_date": "December 7, 2017",
    "session_type": "632. Chronic Myeloid Leukemia: Therapy: Poster I",
    "abstract_text": "Background and Aims. Second generation tyrosine kinase inhibitors (2G-TKI) dasatinib (DAS) and nilotinib (NIL) have been recently licensed for the first-line treatment of patients (pts) with chronic myeloid leukemia (CML) of any age. However, real-life data related to the toxicity and efficacy of 2G-TKI in elderly CML pts are still lacking. To address this issue, we revised a cohort of 126 CML pts in chronic phase aged >65 years and treated frontline with 2G-TKI in 33 Italian Centers. Methods. Data from all consecutive CML pts aged >65 years treated frontline with 2G-TKI in both clinical trials and in the real-life setting from 10/2007 to 11/2016 at each participating Center were collected, focusing on efficacy and toxicity. Seventy-two pts were treated with DAS and 54 pts with NIL. The main clinical features of the pts at diagnosis are reported in the Table. In the DAS group, pts were significantly older and with a worse ECOG PS. Results. In the DAS group, the median interval from diagnosis to treatment was 23 days (IQR 14 - 32). The DAS starting dose was 100 mg/day in 61 pts (84.7%) and <100 mg/day in 11 pts (15.3%). Grade 3-4 hematologic and extra-hematologic toxicities were recorded in 8 (11.1%) and 12 (16.7%) pts, respectively. DAS therapy was permanently discontinued in 12 pts (16.6%) due to toxicity (in 6 pts during the first 12 months of treatment and in 6 subsequently). Pleural effusions of all WHO grades occurred in 14 pts (19.4%) after a median period of DAS treatment of 3.6 months (IQR 1.4 - 13.1): in 5 of them, pleural effusion occurred during the first 3 months. Overall, 66/72 pts (91.6%) achieved a complete cytogenetic response (CCyR), 56/72 (77.7%) a major molecular response (MR3) and 29/72 (40.3%) a deep molecular response (MR4.0/4.5). After a median treatment period of 27.8 months (IQR 19.1 - 37.5), 7 pts have died (1 due to a blastic transformation and 6 for unrelated causes). The cumulative overall survival at 24 months was 90.4% (95% CI 82.9 - 97.9). In the NIL group, the median interval from diagnosis to treatment was 27 days (IQR 15 - 71). The NIL starting dose was 600 mg/day in 49 pts (90.7%), 800 mg/day in 3 patients (5.6%) and <600 mg/day in 2 pts (3.7%), respectively. Grade 3-4 hematologic and extra-hematologic toxicities were detected in 5 (9.3%) and 10 (18.6%) pts, respectively. NIL therapy was permanently discontinued in 7 pts (13.0%) due to toxicity (in 1 pt during the first 12 months of treatment and in 6 subsequently). Grade 3-4 cardiovascular toxicities occurred in 7 pts (13.0%). Overall, 51/54 patients (94.4%) achieved a CCyR, 47/54 (87.0%) a major molecular response (MR3) and 30/54 (55.5%) a deep molecular response (MR 4.0/4.5). After a median treatment period of 41.1 months (IQR 20.3 - 52.6), 5 pts have died from unrelated causes. The cumulative overall survival at 24 months was 95.7% (95% CI 89.8 - 100). Conclusions. The present data shows that 2G-TKI could have a major role in the treatment of real-life CML pts aged >65 years. Indeed, both DAS and NIL proved very effective and with a favorable safety profile also in elderly subjects with comorbidities. View large Download slide View large Download slide  Close modal Disclosures Abruzzese: Pfizer: Consultancy; Novartis: Consultancy; BMS: Consultancy; Incyte: Consultancy. Castagnetti: Incyte: Consultancy, Honoraria; Novartis: Consultancy, Honoraria; Bristol-Myers Squibb: Consultancy, Honoraria; Pfizer: Consultancy, Honoraria. Iurlo: Pfizer: Consultancy, Honoraria; Novartis: Consultancy, Honoraria; Bristol Myers Squibb: Consultancy, Honoraria. Bocchia: Novartis: Other: Travel grant; Celgene: Other: Travel grant; Roche: Other: Travel grant; Jansen: Other: Travel grant. Crugnola: Novartis: Honoraria; BMS: Honoraria; Celgene: Honoraria. Fava: Incyte: Consultancy, Honoraria; Pfizer: Consultancy, Honoraria; Novartis: Consultancy, Honoraria. Bonifacio: Bristol-Myers Squibb: Membership on an entity's Board of Directors or advisory committees; Pfizer: Membership on an entity's Board of Directors or advisory committees; Novartis: Membership on an entity's Board of Directors or advisory committees, Research Funding; Incyte: Membership on an entity's Board of Directors or advisory committees. Galimberti: Novartis: Speakers Bureau; Bristol-Myers Squibb: Speakers Bureau; Pfizer: Speakers Bureau; Incyte: Speakers Bureau. Tiribelli: Incyte: Consultancy, Honoraria; Novartis: Consultancy, Honoraria; Bristol Myers Squibb: Consultancy, Honoraria. Breccia: Novartis: Consultancy; Bristol Myers Squibb: Consultancy; Pfizer: Consultancy; Incyte: Consultancy. Rosti: Bristol Myers Squibb: Research Funding, Speakers Bureau; Pfizer: Research Funding, Speakers Bureau; Incyte: Research Funding, Speakers Bureau; Novartis: Research Funding, Speakers Bureau. Foa: Gilead: Consultancy, Speakers Bureau; Amgen: Consultancy, Speakers Bureau; Novartis: Consultancy, Speakers Bureau; Abbvie: Consultancy, Speakers Bureau; Roche: Consultancy, Speakers Bureau; Janssen: Consultancy, Speakers Bureau; Celgene: Consultancy, Speakers Bureau; BMS: Consultancy, Speakers Bureau; Sandoz: Consultancy, Speakers Bureau.",
    "topics": [
        "leukemia, myelocytic, chronic",
        "older adult",
        "protein-tyrosine kinase inhibitor",
        "brachial plexus neuritis",
        "toxic effect",
        "pleural effusion",
        "time-to-treatment",
        "cardiotoxicity",
        "dasatinib",
        "electrocorticogram"
    ],
    "author_names": [
        "Fabio Stagno, MD PhD",
        "Roberto Latagliata",
        "Mario Annunziata, MD",
        "Elisabetta Abruzzese, MD",
        "Fausto Castagnetti, MD",
        "Alessandra Iurlo, MD PhD",
        "Monica Bocchia",
        "Monica Crugnola, MD",
        "Nicola Sgherza",
        "Attilio Guarini, MD",
        "Federica Sor\u00e0, MD",
        "Isabella Capodanno",
        "Carmen Fava, MD PhD",
        "Antonella Gozzini, MD",
        "Massimiliano Bonifacio, MD",
        "Sabrina Crescenzi Leonetti, MD",
        "Sara Galimberti, PhD MD",
        "Costanzo Feo, MD",
        "Enrico Montefusco",
        "Mario Tiribelli, MD",
        "Patrizia Pregno, MD",
        "Micaela Bergamaschi, MD",
        "Manuela Rizzo, MD",
        "Agostino Antolino",
        "Endri Mauro, MD",
        "Antonella Russo Rossi, MD",
        "Bruno Martino",
        "Raffaele Palmieri, MD",
        "Maria Rosaria Esposito, MD",
        "Maria Iovine, MD",
        "Paolo Danise",
        "Antonello Sica, MD",
        "Paolo Vigneri, MD PhD",
        "Massimo Breccia, MD PhD",
        "Gianantonio Rosti, MD",
        "Robin Foa, MD",
        "Luigiana Luciano"
    ],
    "author_dict_list": [
        {
            "author_name": "Fabio Stagno, MD PhD",
            "author_affiliations": [
                "Chair and Hematology Section, Ferrarotto Hospital, Catania, Italy "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Roberto Latagliata",
            "author_affiliations": [
                "Department of Cellular Biotechnologies and Hematology, Hospital, Rome, Italy "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mario Annunziata, MD",
            "author_affiliations": [
                "Hematology, Ospedale Cardarelli, NAPOLI, Italy "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Elisabetta Abruzzese, MD",
            "author_affiliations": [
                "Hematology Unit, S.Eugenio Hospital, Tor Vergata University, Rome, ITA "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Fausto Castagnetti, MD",
            "author_affiliations": [
                "Hematology/Oncology \"Seragnoli\", University of Bologna, Bologna, Italy "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alessandra Iurlo, MD PhD",
            "author_affiliations": [
                "Hematology Division, IRCCS C\u00e0 Granda - Maggiore Policlinico Hospital Foundation, Milano, Italy "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Monica Bocchia",
            "author_affiliations": [
                "Hematology, University of Siena, Siena, Italy "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Monica Crugnola, MD",
            "author_affiliations": [
                "Division of Hematology, University Hospital of Parma, Parma, Italy "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Nicola Sgherza",
            "author_affiliations": [
                "Division of Hematology, IRCCS Ospedale Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Attilio Guarini, MD",
            "author_affiliations": [
                "Hematology Unit - Oncological Department, Istituto Tumori Giovanni Paolo II I.R.C.C.S. Ospedale Oncologico, Bari, Bari, Italy "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Federica Sor\u00e0, MD",
            "author_affiliations": [
                "Institute of Hematology, Catholic University of Rome, Rome, Italy "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Isabella Capodanno",
            "author_affiliations": [
                "Hematology Unit, Arcispedale Santa Maria Nuova IRCCS, Reggio Emilia, Italy "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Carmen Fava, MD PhD",
            "author_affiliations": [
                "Department of Clinical and Biological Sciences, University of Turin, Orbassano, Turin, Italy "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Antonella Gozzini, MD",
            "author_affiliations": [
                "SC Terapie Cellulari e Medicina Trasfusionale, AOU Careggi, Florence, Italy "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Massimiliano Bonifacio, MD",
            "author_affiliations": [
                "Department of Medicine, Section of Hematology, University of Verona, Verona, Italy "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sabrina Crescenzi Leonetti, MD",
            "author_affiliations": [
                "Hematology, Sandro Pertini Hospital, Rome, Italy "
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sara Galimberti, PhD MD",
            "author_affiliations": [
                "Hematology Division, AOUP, Pisa, Italy "
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Costanzo Feo, MD",
            "author_affiliations": [
                "Hematology, Rummo Hospital, Benevento, Italy "
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Enrico Montefusco",
            "author_affiliations": [
                "POLICLINICO ST. ANDREA, ROME, ITA "
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mario Tiribelli, MD",
            "author_affiliations": [
                "Division of Hematology and BMT, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy "
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Patrizia Pregno, MD",
            "author_affiliations": [
                "AZ OSP CITTA' DELLA SALUTE E SCIENZA TORINO, University of Torino, TORINO, Italy "
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Micaela Bergamaschi, MD",
            "author_affiliations": [
                "Division of Hematology 1, IRCCS AOU San Martino-IST, Genova, Italy "
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Manuela Rizzo, MD",
            "author_affiliations": [
                "Hematology, Tor Vergata University, Rome, Italy "
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Agostino Antolino",
            "author_affiliations": [
                "Hematology, ASP7, Ragusa, ITA "
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Endri Mauro, MD",
            "author_affiliations": [
                "Department of Internal Medicine, General Hospital, Pordenone, Italy "
            ],
            "author_rank": 25,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Antonella Russo Rossi, MD",
            "author_affiliations": [
                "Hematology, University of Bari, Bari, ITA "
            ],
            "author_rank": 26,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Bruno Martino",
            "author_affiliations": [
                "Haematology Dept.- Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria, Italy "
            ],
            "author_rank": 27,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Raffaele Palmieri, MD",
            "author_affiliations": [
                "Hematology, Moscati Hospital, Avellino, Italy "
            ],
            "author_rank": 28,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria Rosaria Esposito, MD",
            "author_affiliations": [
                "Hematology Unit, Ascalesi Hospital, Naples, ITA "
            ],
            "author_rank": 29,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria Iovine, MD",
            "author_affiliations": [
                "Hematology - Oncology Unit, Sant'Anna San Salvatore Hospital, Caserta, Italy "
            ],
            "author_rank": 30,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Paolo Danise",
            "author_affiliations": [
                "Hematology, Pagani Hospital, Salerno, Italy "
            ],
            "author_rank": 31,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Antonello Sica, MD",
            "author_affiliations": [
                "Hematology Unit, Luigi Vanvitelli University, Naples, Italy "
            ],
            "author_rank": 32,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Paolo Vigneri, MD PhD",
            "author_affiliations": [
                "Dep. Clinical and Experimental Medicine, University of Catania Medical School, Catania, Italy "
            ],
            "author_rank": 33,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Massimo Breccia, MD PhD",
            "author_affiliations": [
                "Dipartimento Biotecnologie Cellulari, University of Rome \"Sapienza\", Roma, Italy "
            ],
            "author_rank": 34,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Gianantonio Rosti, MD",
            "author_affiliations": [
                "Department of Experimental, Diagnostic and Specialty Medicine - DIMES, Institute of Hematology \"L. and A. Ser\u00e0gnoli\", S.Orsola-Malpighi University Hospital, Bologna, Italy "
            ],
            "author_rank": 35,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Robin Foa, MD",
            "author_affiliations": [
                "Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Policlinico Umberto I, Rome, Italy "
            ],
            "author_rank": 36,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Luigiana Luciano",
            "author_affiliations": [
                "AOU Universit\u00e0 degli Studi di Napoli \"Federico II\", Napoli, Italy"
            ],
            "author_rank": 37,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-10T15:39:10",
    "is_scraped": "1"
}